2m 2m 2m 2m 2m 2m 2m
Aclaris Therap (ACRS)
NASDAQ
$4.89-$0.03 (-0.53%)
Price as of Jun 23, 2026 7:53 PM EDT- $676.0MMarket Cap
- 223.68%1-Year Change
- BiotechnologyIndustry
Aclaris Therap (ACRS)
$4.89-$0.03 (-0.53%)
ACRS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.92 | ||
Change | +$0.08 (+1.65%) | ||
Open | $4.77 | ||
High | $5.12 | ||
Low | $4.77 | ||
Previous Close | $4.84 | ||
Volume | 1,865,406 | ||
30-Day Average Volume | 1,407,062 | ||
1-Week Change | 13.36% | ||
1-Month Change | 8.85% | ||
1-Year Change | 223.68% | ||
3-Year Change | -52.00% | ||
5-Year Change | -71.45% | ||
Fundamentals | |||
Shares Outstanding | 139.7M | ||
Total Assets | $198.7M | ||
Market Cap | $676.0M | ||
Enterprise Value | $647.3M | ||
Period: QTR TTM FY | |||
Revenue | $537,000.00 | ||
Net Income | -$19.8M | ||
Free Cash Flow | -$18.2M | ||
EBIT | -$19.8M | ||
EBITDA | -$19.7M | ||
Net Working Capital | $82.9M | ||
EPS | -$0.15 | ||
Enterprise Value/EBITDA | -33 | ||
Enterprise Value/Revenue | 1,205 | ||
P/B | 5 | ||
P/E | -32 | ||
PEG | -5 | ||
Price/Free Cash Flow | -37 | ||
Price/Operating Cash Flow | -37 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue